1. Altinkilic, Emre Murat, Isbir, Selim, Gormus, Uzay, Duman, Selvi, Isbir, Turgay. . RRM1, RRM2 and ERCC2 Gene Polymorphisms in Coronary Artery Disease. In In vivo (Athens, Greece), 30, 611-5. doi:. https://pubmed.ncbi.nlm.nih.gov/27566080/
2. Chen, Dar-Ren, Chuang, Chun-Yi, Wu, Buor-Chang, Peng, Yu-Hsien, Tsai, Hsiu-Ting. 2014. Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer. In Journal of clinical laboratory analysis, 28, 287-93. doi:10.1002/jcla.21682. https://pubmed.ncbi.nlm.nih.gov/24578158/
3. Yang, Zituo, Wong, Sek Man, Yue, Gen Hua. 2021. Effects of rrm1 on NNV Resistance Revealed by RNA-seq and Gene Editing. In Marine biotechnology (New York, N.Y.), 23, 854-869. doi:10.1007/s10126-021-10068-x. https://pubmed.ncbi.nlm.nih.gov/34735644/
4. Mlak, Radosław, Powrózek, Tomasz, Brzozowska, Anna, Mazurek, Marcin, Małecka-Massalska, Teresa. . RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients. In Cancer biomarkers : section A of Disease markers, 22, 657-667. doi:10.3233/CBM-171082. https://pubmed.ncbi.nlm.nih.gov/29865035/
5. Wang, Lin-run, Zhang, Guo-bing, Chen, Jian, Wang, Yang, Shen Tu, Jian-zhong. . RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum. In Journal of Zhejiang University. Science. B, 12, 174-9. doi:10.1631/jzus.B1000197. https://pubmed.ncbi.nlm.nih.gov/21370501/
6. Li, Borui, Xing, Faliang, Wang, Jingyi, Qin, Yi, Li, Zheng. 2024. YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer. In Cancer letters, 602, 217197. doi:10.1016/j.canlet.2024.217197. https://pubmed.ncbi.nlm.nih.gov/39216548/
智鼠故事 
